Clinical value of C-reactive protein measurements in HIV-positive patients

International Journal of STD and AIDS

Volumn 16, Issue 6, 2005, Pages 438-441

  Noursadeghi, Mahdad ^a   Miller, Robert F ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute phase protein; C reactive protein; Fever; HIV; Infection

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL;

ACUTE-PHASE REACTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HIV ANTIBODIES; HIV-1; HUMANS; MALE;

EID: 20944433273     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462054094006     Document Type: Article

References (13)

1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12
2. Florence E, Bottieau E, Lynen L, Colebunders R. Patients with HIV infection and fever: a diagnostic approach. Acta Clin Belg 2002;57:184-90
3. Sullivan M, Feinberg J, Bartlett JG. Fever in patients with HIV infection. Infect Dis Clin North Am 1996;10:149-65
4. Arango CA, Midani S, Alvarez A, Kubilis PS, Rathore MH. Usefulness of acute phase reactants in the diagnosis of acute infections in HIV-infected children. South Med J 1999;92:209-13
5. Diculencu D, Apetrei C, Iancu LS, Bosnea D. The role of C-reactive protein (CRP) determination in the early diagnosis of infections with opportunistic microorganisms in HIV-infected children. Rev Med Chir Soc Med Nat Iasi 1995; 99:139-43
6. Grutzmeier S, Sandstrom E. C-reactive protein levels in HIV complicated by opportunistic infections and infections with common bacterial pathogens. Scand J Infect Dis 1999;31:229-34
7. Lala SG, Madhi SA, Pettifor JM. The discriminative value of C-reactive protein levels in distinguishing between community-acquired bacteraemic and respiratory virus-associated lower respiratory tract infections in HIV-1-infected and -uninfected children. Ann Trop Paediatr 2002;22:271-9
8. Lawn SD, Wiktor S, Coulibaly D, Ackah AN, Lal RB. Serum C-reactive protein and detection of tuberculosis in persons co-infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 2001;95:41-2
9. Syrjala H, Lahdevirta J, Ruutu P, Jokipii L, Jokipii AM, Ruutu T. Acute phase response in Pneumocystis carinii pneumonia. Scand J Infect Dis 1990;22:713-16
10. Pitkin AD, Grant AD, Foley NM, Miller RF. Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1. Thorax 1993;48:204-7
11. Miller RF, Hingorami AD, Foley NM. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDS. Int J STD AIDS 1996;7: 170-5
12. Miller RF, Hall-Craggs MA, Costa DC, et al. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex Transm Infect 1998;74:258-64
13. Jahoor F, Gazzard B, Phillips G, et al. The acute-phase protein response to human immunodeficiency virus infection in human subjects. Am J Physiol 1999;276:E1092-8